You are here

  • Home
  • Archive
  • Volume 68, Issue Suppl 3
  • P101 Does Ivacaftor improve objective measurements of health in patients with the G551D cystic fibrosis transmembrane conductance regulator (CFTR) protein mutation? The experience of a UK cystic fibrosis centre

Citation Tools

Article menu

Download PDFPDF

Bronchiectasis
P101 Does Ivacaftor improve objective measurements of health in patients with the G551D cystic fibrosis transmembrane conductance regulator (CFTR) protein mutation? The experience of a UK cystic fibrosis centre
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Ewence A, Eruchie C, Higton A, et al
P101 Does Ivacaftor improve objective measurements of health in patients with the G551D cystic fibrosis transmembrane conductance regulator (CFTR) protein mutation? The experience of a UK cystic fibrosis centre
Thorax 2013;68:A120.